AAAAAA

   
Results: 1-11 |
Results: 11
ROPINIROLE FOR THE TREATMENT OF EARLYPARKINSON-DISEASE - A 12-MONTH EXPERIENCE
Authors: SETHI KD OBRIEN CF HAMMERSTAD JP ADLER CH DAVIS TL TAYLOR RL SANCHEZRAMOS J BERTONI JM HAUSER RA
Citation: Kd. Sethi et al., ROPINIROLE FOR THE TREATMENT OF EARLYPARKINSON-DISEASE - A 12-MONTH EXPERIENCE, Archives of neurology, 55(9), 1998, pp. 1211-1216
EFFECTS OF PALLIDOTOMY ON DYSKINESIAS AND MOTOR SIGNS IN PARKINSONS-DISEASE
Authors: GANCHER ST CARTER JH HAMMERSTAD JP CALHOUN D
Citation: St. Gancher et al., EFFECTS OF PALLIDOTOMY ON DYSKINESIAS AND MOTOR SIGNS IN PARKINSONS-DISEASE, Annals of neurology, 42(3), 1997, pp. 213-213
ROPINIROLE FOR THE TREATMENT OF EARLY PARKINSONS-DISEASE
Authors: ADLER CH SETHI KD HAUSER RA DAVIS TL HAMMERSTAD JP BERTONI J TAYLOR RL SANCHEZRAMOS J OBRIEN CF
Citation: Ch. Adler et al., ROPINIROLE FOR THE TREATMENT OF EARLY PARKINSONS-DISEASE, Neurology, 49(2), 1997, pp. 393-399
BILATERAL DEEP-BRAIN STIMULATION FOR PARKINSONS-DISEASE - COMPARISON OF PALLIDAL VERSUS SUBTHALAMIC NUCLEUS TARGETS
Authors: HAMMERSTAD JP BURCHIEL KJ FAVRE J TAHA J GANCHER S ANDERSON VC
Citation: Jp. Hammerstad et al., BILATERAL DEEP-BRAIN STIMULATION FOR PARKINSONS-DISEASE - COMPARISON OF PALLIDAL VERSUS SUBTHALAMIC NUCLEUS TARGETS, Neurology, 48(3), 1997, pp. 12002-12002
JAW MOVEMENT DYSFUNCTION RELATED TO PARKINSONS-DISEASE AND PARTIALLY MODIFIED BY LEVODOPA
Authors: ROBERTSON LT HAMMERSTAD JP
Citation: Lt. Robertson et Jp. Hammerstad, JAW MOVEMENT DYSFUNCTION RELATED TO PARKINSONS-DISEASE AND PARTIALLY MODIFIED BY LEVODOPA, Journal of Neurology, Neurosurgery and Psychiatry, 60(1), 1996, pp. 41-50
PATTERNS OF ASYMMETRY DO NOT CHANGE OVER THE COURSE OF IDIOPATHIC PARKINSONISM - IMPLICATIONS FOR PATHOGENESIS
Authors: LEE CS SCHULZER M MAK E HAMMERSTAD JP CALNE S CALNE DB
Citation: Cs. Lee et al., PATTERNS OF ASYMMETRY DO NOT CHANGE OVER THE COURSE OF IDIOPATHIC PARKINSONISM - IMPLICATIONS FOR PATHOGENESIS, Neurology, 45(3), 1995, pp. 435-439
TENDON JERKS IN PARKINSONS-DISEASE
Authors: HAMMERSTAD JP ELLIOTT K MAK E SCHULZER M CALNE S CALNE DB
Citation: Jp. Hammerstad et al., TENDON JERKS IN PARKINSONS-DISEASE, Journal of neural transmission. Parkinson's disease and dementia section, 8(1-2), 1994, pp. 123-130
CONTROLLED-RELEASE LEVODOPA CARBIDOPA-25/100 (SINEMET CR-25/100) - PHARMACOKINETICS AND CLINICAL EFFICACY IN UNTREATED PARKINSONIAN-PATIENTS/
Authors: HAMMERSTAD JP WOODWARD WR NUTT JG GANCHER ST BLOCK GA CYHAN G
Citation: Jp. Hammerstad et al., CONTROLLED-RELEASE LEVODOPA CARBIDOPA-25/100 (SINEMET CR-25/100) - PHARMACOKINETICS AND CLINICAL EFFICACY IN UNTREATED PARKINSONIAN-PATIENTS/, Clinical neuropharmacology, 17(5), 1994, pp. 429-434
EFFECT OF PERIPHERAL CATECHOL-O-METHYLTRANSFERASE INHIBITION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA IN PARKINSONIAN-PATIENTS
Authors: NUTT JG WOODWARD WR BECKNER RM STONE CK BERGGREN K CARTER JH GANCHER ST HAMMERSTAD JP GORDIN A
Citation: Jg. Nutt et al., EFFECT OF PERIPHERAL CATECHOL-O-METHYLTRANSFERASE INHIBITION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA IN PARKINSONIAN-PATIENTS, Neurology, 44(5), 1994, pp. 913-919
THE TRANSPORT OF L-6-FLUORODOPA AND ITS METABOLITES FROM BLOOD TO CEREBROSPINAL-FLUID AND BRAIN
Authors: HAMMERSTAD JP PATE BD HEWITT KA CHAN GLY RUTH TJ CALNE DB
Citation: Jp. Hammerstad et al., THE TRANSPORT OF L-6-FLUORODOPA AND ITS METABOLITES FROM BLOOD TO CEREBROSPINAL-FLUID AND BRAIN, Annals of neurology, 34(4), 1993, pp. 603-608
EFFECTS OF AN INHIBITOR OF CATECHOL-O-METHYL TRANSFERASE (COMT) ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA
Authors: NUTT JG WOODWARD WR STONE CK BECKNER RM CARTER JH GANCHER ST HAMMERSTAD JP GORDIN A
Citation: Jg. Nutt et al., EFFECTS OF AN INHIBITOR OF CATECHOL-O-METHYL TRANSFERASE (COMT) ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA, Neurology, 43(4), 1993, pp. 332-332
Risultati: 1-11 |